Targeting the mitochondria in COVID‑19 pneumonia: The cardiopulmonary effects of a SARS-CoV-2 mitochondriopathy
Archer, Stephen L |
Queen's University | Project Grant | $422,280
CIHR Ontario 2021
Read More
Addressing unmet and emerging health needs of Canadian adults with intellectual and developmental disabilities and their families during COVID-19
Lunsky, Yona J |
Centre for Addiction and Mental Health | Operating Grant | $246,441
CIHR Ontario 2021
Read More
Improving the recognition and care of patients with long-term health complications of COVID-19
Quinn, Kieran L |
Sinai Health System | Operating Grant | $499,998
CIHR Ontario 2021
Read More
Quality of Death in Hospital and Bereavement Outcomes in the COVID‑19 Era
Nissim, Rinat |
University Health Network | Project Grant | $294,525
CIHR Ontario 2021
Read More
COVID-19 Variant Supplement – Neutralizing Antibodies as SARS-CoV-2 Therapeutics
Rini, James M |
University of Toronto | Operating Grant | $50,000
CIHR Ontario 2021
Read More
SARS-CoV-2 triggers Autoimmunity: implications for the pathogenesis of Post-Acute COVID‑19 Syndrome – (AI-PACS)
Mukherjee, Manali |
McMaster University | Operating Grant | $499,245
CIHR Ontario 2021
Read More
COVID-19 Variant Network – Implementation of serological and molecular tools to inform COVID‑19 patient management
Lerner-Ellis, Jordan P |
Sinai Health System | Operating Grant | $100,000
CIHR Ontario 2021
Read More
SARS-CoV-2 genotype-dependent pathogenesis and transmission
Mubareka, Samira |
Sunnybrook Research Institute | Project Grant | $612,765
CIHR Ontario 2021
Read More
COVID-19 Variant Supplement – Development of Vaccines to Prevent SARS-CoV-2 Infection of High Risk Individuals
Bell, John C |
Ottawa Hospital Research Institute | Operating Grant | $50,000
CIHR Ontario 2021
Read More
Targeting the novel coronavirus SARS-CoV-2 using an ancient antibody system
Ehrhardt, Rudolf A |
University of Toronto | Project Grant | $229,500
CIHR Ontario 2021
Read More
